JB Pharma acquires 4 pediatric brands from Dr Reddys
The acquisition has been done for a cash consideration of Rs 98.3 crores.
New Delhi: J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has recently announced that the Board of Directors of the company has approved the acquisition of portfolio of brands, for use and exploitation within India, from Dr Reddy's Laboratories Limited.
The acquisition has been done for a cash consideration of Rs 98.3 crores. The acquisition shall be funded primarily through long term debt.
"The Acquisition shall be completed within next few working days," the company further said.
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751